BSR: Early Tx Response Predicts 2-Year AS Outcomes (CME/CE)

(MedPage Today) -- Improvement in first 3 months on secukinumab tied to better long-term response
Source: MedPage Today Pain Management - Category: Anesthesiology Source Type: news